ArlettCFHarcourtSAColeJGreenMHLAnsteyAV. A comparison of the response of unstimulated and stimulated T-lymphocytes and fibroblasts from normal, xeroderma pigmentosum and trichothiodystrophy donors to the lethal action of UV-C. Mutat Res1992;273:127–35.
2.
ColeJArlettCFNorrisPGStephensGWaughAPWBeareDM. Elevated HPRT mutant frequency in circulating T-lymphocytes of xeroderma pigmentosum patients. Mutat Res1992;273:171–8.
3.
LehmannARKirk-BellSArlettCFPatersonMCLohmanPHMWeerd-KasteleinEA. Xeroderma pigmentosum cells with normal levels of excision repair have a defect in DNA synthesis after UV irradiation. Proc Natl Acad Sci USA1975;72:219–23.
4.
KraemerKHDiGiovannaJJMoshellANTaroneREPeckGL. Prevention of skin cancer in xeroderma pigmentosum with use of oral isotretinoin. N Engl J Med1988;318:1633–7.
5.
PichlerEFritschP. Xeroderma pigmentosum: Tumorprophylaxe mit Etretinate. Hautarzt1984;35:159–61.
6.
StrongA. Xeroderma pigmentosum variant: Prevention of cutaneous neoplasms with etretinate. In: Retinoids today and tomorrow, Vol 17. London: Mediscript, 1989:40–2.
